Skip to content
ApprovedFDA approvedStrong evidence

Clomipramine

Tricyclic antidepressant (Anafranil), the most serotonergic TCA, FDA-approved for OCD.

AntidepressantTricyclic antidepressantAntidepressantMoodSerotoninNorepinephrine

Pharmacology

ClassAntidepressant · Mood
Primary targetSerotonin transporter (SERT) reuptake inhibition
Targets5 receptor targets
Half-lifeClomipramine ~32 hours; its active metabolite (desmethylclomipramine) is longer, ~54-77 hours
OnsetAnxiolytic/antidepressant effect develops over 2-6 weeks
EvidenceStrong evidence
Affected systemsSerotoninNorepinephrine

Contents

WHAT IS CLOMIPRAMINE?

Detailed overview

Clomipramine (Anafranil) is a tricyclic antidepressant (TCA) that raises synaptic monoamine levels by inhibiting the serotonin and norepinephrine transporters; it is the most strongly serotonergic of all TCAs. The FDA approved it for obsessive-compulsive disorder (OCD), and numerous randomized trials also support its efficacy in depression, panic disorder and on-demand treatment of premature ejaculation. Its side-effect burden comes from simultaneous blockade of histamine, muscarinic and alpha-1 receptors (sedation, dry mouth, orthostasis). It is a prescription-only medicine that must be used under medical supervision; overdose is cardiotoxic and life-threatening.

Mechanism

Serotonin and norepinephrine reuptake inhibition (TCA)

Main indication

OCD (FDA-approved), depression, panic

Legal status

Prescription-only medicine

Receptor profile

  • Serotonin transporter (SERT)Strong
  • Norepinephrine transporter (via active metabolite)Strong
  • Histamine H1 receptorModerate
  • Muscarinic acetylcholine receptorsModerate
  • Alpha-1 adrenergic receptorModerate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Anticholinergic effects: dry mouth, constipation, blurred vision, urinary retention
  • Sedation, drowsiness and weight gain from H1 blockade
  • Orthostatic hypotension and dizziness from alpha-1 blockade
  • Sexual dysfunction: delayed or inhibited orgasm, reduced libido
  • Sweating, tremor, dose-dependent seizure risk (lowering of the seizure threshold)
  • Cardiotoxicity in overdose: QT prolongation, arrhythmia; TCA overdose is life-threatening

Contraindications · 5

  • With an MAO inhibitor or within 14 days of stopping one: risk of serotonin syndrome
  • Recent myocardial infarction, severe conduction disorder or known QT prolongation
  • Narrow-angle glaucoma, clinically significant prostate enlargement (urinary retention)
  • Epilepsy or lowered seizure threshold: increased seizure risk
  • Manic phase; increased suicidal ideation risk in children and young adults, close monitoring required

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Tricyclic antidepressant (Anafranil), the most serotonergic TCA, FDA-approved for OCD.

Telegram

Have a question about Clomipramine?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAntidepressant
FormulaC19H23ClN2
UpdatedJuly 10, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: July 10, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.